ArticleCancers2022

Exploring Real World Outcomes with Nivolumab Plus Ipilimumab in Patients with Metastatic Extra-Pulmonary Neuroendocrine Carcinoma (EP-NEC).

Amr Mohamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.